SILVER SPRING, Md., March 12, 2019 /PRNewswire/ -- A federal court ordered a Texas-based company to stop producing compounded drug products intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and other requirements. According to the...